SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Citius Oncology Gets Nasdaq Extension to Meet Nasdaq Bid Price Rule

Citius Oncology received an extension through April 19, 2027, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.

CTOR

Related stories